Growth Hormone Secretagogues · Research deep dive
IGF-1 LR3: the cited literature
Every study referenced in the IGF-1 LR3 monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, IGF-1 LR3 is studied at 20 mcg – 50 mcg per administration, typically once daily. The reference walkthrough below maps each citation to what it actually showed.
References covered
Long-R3-IGF-I and cell culture applications
Cytotechnology, 1992
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for IGF-1 LR3.